Dr. Wang Lihua (王丽华) - Director of Gynecology at Ruijin Hospital, Shanghai Jiao Tong University

About Dr. Wang Lihua

Dr. Wang Lihua (王丽华) is one of China's most distinguished gynecologists and the Director of the Department of Gynecology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. She holds the title of Chief Physician and Professor and is nationally recognized as a leading authority on gynecologic oncology, minimally invasive gynecologic surgery, and endometriosis.

Over a career spanning more than three decades, Dr. Wang has established Ruijin Hospital's Gynecology Department as one of the premier women's surgical centers in Shanghai. She is particularly renowned for her expertise in laparoscopic and robotic gynecologic surgery, cervical and endometrial cancer management, and complex endometriosis surgery — areas where her technical precision and clinical outcomes have earned her a national reputation.

International patients with gynecologic cancers, endometriosis, uterine fibroids, or other complex gynecologic conditions consistently identify Dr. Wang as one of Shanghai's top gynecologists for both primary surgical treatment and expert second opinions.

Professional Positions and Affiliations

• Director, Department of Gynecology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
• Vice Chairwoman, Gynecologic Oncology Committee, Chinese Society of Obstetrics and Gynecology
• Member, Minimally Invasive Gynecology Committee, Chinese Society of Obstetrics and Gynecology
• Editorial Board Member: Chinese Journal of Obstetrics and Gynecology, Journal of Minimally Invasive Gynecology
• Member, International Gynecologic Cancer Society (IGCS)
• Member, European Society of Gynaecological Oncology (ESGO)

Specialties and Clinical Expertise

Dr. Wang's clinical practice covers the full spectrum of gynecologic disease, with particular depth in oncology and minimally invasive surgery. Her approach integrates the latest surgical techniques with multidisciplinary systemic therapy planning.

• Cervical Cancer — radical hysterectomy (open, laparoscopic, and robotic); fertility-sparing radical trachelectomy for early-stage disease in young patients; sentinel lymph node mapping; coordination with radiation oncology for concurrent chemoradiation
• Endometrial Cancer — laparoscopic and robotic staging surgery; sentinel lymph node biopsy; fertility-sparing management with progestin therapy for early-stage disease; coordination with medical oncology for adjuvant therapy (carboplatin/paclitaxel, pembrolizumab for MSI-H tumors)
• Ovarian Cancer — primary debulking surgery and interval debulking after neoadjuvant chemotherapy; HIPEC coordination; BRCA testing and PARP inhibitor maintenance therapy
• Endometriosis — deep infiltrating endometriosis (DIE) surgery including bowel, bladder, and ureteral endometriosis; endometrioma excision with ovarian reserve preservation; pain management and fertility coordination
• Uterine Fibroids (Myomas) — laparoscopic and robotic myomectomy; hysteroscopic resection for submucosal fibroids; uterine artery embolization coordination
• Minimally Invasive Gynecologic Surgery — laparoscopic and robotic hysterectomy, adnexal surgery, and pelvic floor reconstruction; single-port laparoscopy
• Abnormal Uterine Bleeding — hysteroscopic evaluation and treatment; endometrial ablation; hormonal management
• Pelvic Organ Prolapse — laparoscopic sacrocolpopexy and native tissue repair; coordination with urogynecology
• Hereditary Gynecologic Cancer — BRCA1/2 and Lynch syndrome carriers; risk-reducing surgery and surveillance protocols

Academic and Research Contributions

Dr. Wang Lihua has published over 150 peer-reviewed papers in leading international gynecology journals, with a particular focus on minimally invasive surgical techniques for gynecologic cancer, fertility-sparing approaches for early-stage cervical and endometrial cancer, and the surgical management of deep infiltrating endometriosis. Her research on robotic radical trachelectomy for fertility preservation in young cervical cancer patients has been widely cited and has contributed to the adoption of this technique at major Chinese gynecologic oncology centers.

She has led multicenter studies on sentinel lymph node mapping in endometrial cancer — contributing to the validation of this technique in Chinese patients and its incorporation into national guidelines. She is a regular invited speaker at IGCS (International Gynecologic Cancer Society), ESGO (European Society of Gynaecological Oncology), and the Chinese Society of Obstetrics and Gynecology annual congress.

Hospital: Ruijin Hospital Gynecology Department

Under Dr. Wang's leadership, Ruijin Hospital's Gynecology Department operates:

• A dedicated Gynecologic Oncology Program with weekly multidisciplinary tumor board integrating gynecology, medical oncology, radiation oncology, and radiology
• A Robotic Surgery Program with da Vinci Xi capability for radical hysterectomy, myomectomy, and endometriosis surgery
• A Fertility-Sparing Surgery Clinic for young patients with early-stage gynecologic cancers
• An Endometriosis Center with integrated pain management and reproductive medicine support
• A Hereditary Cancer Clinic for BRCA and Lynch syndrome carriers

Why International Patients Choose Dr. Wang Lihua

• Gynecologic oncology expertise — cervical, endometrial, and ovarian cancer surgery at the highest technical level
• Fertility-sparing surgery pioneer — radical trachelectomy and progestin therapy for young patients wishing to preserve fertility
• Robotic surgery capability — offering the least invasive approach for eligible patients
• Deep endometriosis expertise — complex DIE surgery including bowel and bladder involvement
• IGCS and ESGO member — aligned with international gynecologic oncology standards
• BRCA/Lynch syndrome management — risk-reducing surgery and surveillance for hereditary cancer carriers
• English-language support available through CMCS concierge coordination

Practical Information for International Patients

• Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
• Appointment Lead Time: 2″4 weeks for new patients; urgent cases expedited through CMCS
• Consultation Format: In-person consultation; remote pre-consultation imaging and pathology review available through CMCS
• Languages: Mandarin Chinese; English interpretation provided by CMCS
• Medical Records: CMCS provides full translation of overseas imaging, pathology, and treatment records into Chinese prior to consultation

How CMCS Can Help

China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking gynecologic care with Dr. Wang Lihua at Ruijin Hospital. Our services include priority appointment booking, medical record and pathology translation, remote pre-consultation review, on-site interpretation, accommodation coordination, insurance liaison, and post-surgical follow-up with your home country gynecologist or oncologist.

📧 Contact us: contract@medicalsh.com 
🌐 medicalsh.com